共 50 条
- [4] High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial LANCET ONCOLOGY, 2022, 23 (05): : 671 - 681
- [5] FINAL REPORT OF MULTICENTER CANADIAN PHASE III RANDOMIZED TRIAL OF 3 VERSUS 8 MONTHS OF NEOADJUVANT ANDROGEN DEPRIVATION THERAPY BEFORE CONVENTIONAL-DOSE RADIOTHERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (02): : 327 - 333
- [8] High-Dose Radiotherapy With or Without Androgen Deprivation Therapy for Intermediate-Risk Prostate Cancer: Cancer Control and Toxicity Outcomes INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (05): : 1473 - 1479